Global Earth Energy, Inc. (OTC Bulletin Board: GLER) reached up 204.08% in morning trading to $.0149 with 1M shares traded. Through its subsidiary RCI Solar, Inc., Global Earth Energy is a leading solar solutions provider with extensive market experience in systems integration and the development of renewable energy products and services. Global Earth Energy plans to open a Canadian office based in Ontario to fill key contracts from RCI Solar Network. RCI Solar's mission is to make solar energy affordable in the residential, commercial and industrial sectors. RCI Solar offers a wide range of solar, thermo energy and other "go green" alternative products, primarily Solar Domestic Hot Water, Solar Photo Voltaic (PV) Panels and AQUA III Heating & Cooling System. Along with these products, RCI Solar supplies a wide variety of fan convectors, solar storage tanks, controls, inverters, and ancillaries. Global Earth Energy, Inc. (OTC.BB: GLER - News) announced a joint venture with Reflora de Brazil, a Brazilian based company. Involved in Carbon sequestration, Reflora expects that potential gross revenues, which are cited by an independent third party, could exceed $200mm over the next decade, potentially reaching into the billions. Revenues are expected to begin by the third quarter of 2011.
B2Digital (Pink Sheets: BTDG) reached up 107.69% in morning trading to $.0027 with 23M shares traded. B2 Digital is dedicated to seeking acquisitions and joint ventures within the resource sector and in particular mining properties that contain gold and silver reserves. Management of its subsidiary has many years of experience in the exploration and operations of mining assets. B2 Digital is currently in the process of divesting itself of some of its technology assets. B2Digital (Pink Sheets: BTDG - News) to announce major news on Thursday, December 2, 2010, regarding recent buyout offers for all outstanding shares of its common stock.
Icagen, Inc. (Nasdaq: ICGN) reached up 40.16% in morning trading to $1.71 with 900K shares traded. Icagen, Inc. is a biopharmaceutical company based in Research Triangle Park, North Carolina, focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. Utilizing its proprietary know-how and integrated scientific and drug development capabilities, Icagen has identified multiple drug candidates that modulate ion channels. The Company is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. The Company has a clinical stage program in epilepsy and pain. Icagen, Inc. (Nasdaq: ICGN - News) today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7. Based upon data obtained in this study, the companies have now selected one of these compounds to advance into further clinical studies. The selection of this compound has triggered a milestone payment to Icagen of $1.0 million.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
